USANA Health Sciences Stock Forecast for 2023 - 2025 - 2030
Updated on 05/31/2023
USANA Health Sciences Stock Forecast and Price Target
The average target price set lately by experts for USANA Health Sciences to reach by the end of the year is $57.00, which would imply a potential downside of approximately -8.6 percent from the previous closing price if it were to be achieved. This prediction is based on a high estimate of $90.00 and a low estimate of $53.00. Even if you are not interested in USNA stock, you should be aware of its competitors and their current standings.
-8.60% Downside
USANA Health Sciences Fair Value Forecast for 2023 - 2025 - 2030
In the last three years, USANA Health Sciences's Price has grown by 16.09%, rising from $84.00 to $97.52. In the next year, 0 analysts estimate that USANA Health Sciences's Fair Value will decrease by 3.46%, reaching $94.15. According to professional forecasts, in 2030, USANA Health Sciences's Fair Value will decrease by 7.01%, reaching $90.68.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| WMT Stock Forecast | Walmart Inc | Outperform |
14
|
$146.05 | Buy/Sell | $160.94 | 10.24% |
| NESN Stock Forecast | Nestlé | Outperform |
5
|
CHF111.10 | Buy/Sell | CHF122.48 | 8.01% |
| CVS Stock Forecast | CVS Health Corp | Outperform |
13
|
$67.15 | Buy/Sell | $106.45 | 72.08% |
| PRGO Stock Forecast | Perrigo | Buy |
16
|
$31.60 | Buy/Sell | $47.75 | 50.32% |
| SMPL Stock Forecast | The Simply Good Foods | Outperform |
15
|
$35.96 | Buy/Sell | $40.58 | 25.14% |
USANA Health Sciences Revenue Forecast for 2023 - 2025 - 2030
In the last three years, USANA Health Sciences's Revenue has gone down from $1.19B to $1.19B – a 0.23% drop. For next year, analysts predict Revenue of $1.19B, which would mean an increase of 0.41%. According to professional forecasts, in 2030, USANA Health Sciences's Revenue will decrease by 2.55%, reaching $1.16B.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| NUS Stock Forecast | Nu Skin Enterprises | Outperform |
18
|
$33.97 | Buy/Sell | $51.60 | 44.24% |
| HAIN Stock Forecast | The Hain Celestial Group | Outperform |
14
|
$12.67 | Buy/Sell | $36.31 | 168.35% |
| MED Stock Forecast | Medifast | Buy |
18
|
$81.00 | Buy/Sell | $327.33 | 325.93% |
.jpg)
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| HLF Stock Forecast | Herbalife Nutrition | Buy |
16
|
$11.77 | Buy/Sell | $37.00 | 227.10% |
| TUP Stock Forecast | Tupperware Brands | Outperform |
18
|
$1.00 | Buy/Sell | $14.63 | 1100.00% |
| PETS Stock Forecast | PetMed Express | Hold |
16
|
$14.61 | Buy/Sell | $27.00 | 36.89% |
USANA Health Sciences Free Cash Flow Forecast for 2023 - 2025 - 2030
USANA Health Sciences's Free Cash Flow has grown In the last three years, rising from $140.69M to $123.50T – a growth of 87779404.52%. 0 analysts predict USANA Health Sciences's Free Cash Flow will decrease by 32.16% in the next year, reaching $83.78T. By 2030, professionals predict that USANA Health Sciences's Free Cash Flow will decrease by 42.03%, to $71.59T.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| NATR Stock Forecast | Nature's Sunshine Products | Buy |
16
|
$11.00 | Buy/Sell | $24.00 | 122.73% |
| FARM Stock Forecast | Farmer Bros. | Outperform |
11
|
$2.85 | Buy/Sell | $7.00 | 338.60% |
| LWAY Stock Forecast | Lifeway Foods | - |
10
|
$6.01 | Buy/Sell | $7.25 | -88.85% |
USANA Health Sciences Net Income Forecast for 2023 - 2025 - 2030
In the last three years, USANA Health Sciences's Net Income has decreased from $126.22M to $116.51M – a 7.69% drop. In the next year, analysts believe that Net Income will reach $121.63M – an increase of 4.40%. For the next eight years, the forecast is for Net Income to grow by 1.15%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| NHTC Stock Forecast | Natural Health Trends | - |
0
|
$6.74 | Buy/Sell | $0.00 | 255.93% |
| NAII Stock Forecast | Natural Alternatives Internati... | - |
0
|
$9.20 | Buy/Sell | $0.00 | 1633.59% |
| LFVN Stock Forecast | LifeVantage | Hold |
0
|
$3.30 | Buy/Sell | $7.50 | 74.24% |
USANA Health Sciences EBITDA Forecast for 2023 - 2025 - 2030
In the last three years, USANA Health Sciences's EBITDA has decreased from $205.20M to $192.89M – a 6.00% drop. In the next year, analysts believe that EBITDA will reach $199.79M – an increase of 3.58%. In 2030, the professionals' prediction is that USNA's EBITDA will decrease by 1.60%, reaching $189.80M.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| MTEX Stock Forecast | Mannatech | - |
12
|
$16.93 | Buy/Sell | $200.00 | 130.48% |
| RELV Stock Forecast | Reliv' International | - |
0
|
$4.00 | Buy/Sell | $0.00 | -18.50% |
| MSLP Stock Forecast | MusclePharm | - |
0
|
$0.15 | Buy/Sell | $1.65 | 13.33% |
USANA Health Sciences EBIT Forecast for 2023 - 2025 - 2030
USANA Health Sciences's EBIT has decreased by 9.64% In the last three years, from $188.35M to $170.19M. For the next year, analysts predict that EBIT will reach $178.91M – an increase of 5.12%. Over the next eight years, experts believe that USANA Health Sciences's EBIT will grow at a rate of 0.66%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| YGYI Stock Forecast | Youngevity International | - |
0
|
$0.13 | Buy/Sell | $6.00 | 7.69% |
| UMHL Stock Forecast | Umatrin Holding | - |
0
|
$0.02 | Buy/Sell | $0.00 | -100.00% |
| RBCL Stock Forecast | RBC Life Sciences | - |
0
|
$0.00 | Buy/Sell | $0.00 | 0.00% |
USANA Health Sciences EPS Price Prediction Forecast for 2023 - 2025 - 2030
In the last three years, USANA Health Sciences's EPS has grown by 16.09%, rising from $5.16 to $5.99. In the next year, 0 analysts estimate that USANA Health Sciences's EPS will decrease by 3.46%, reaching $5.78. According to professional forecasts, in 2030, USANA Health Sciences's EPS will decrease by 7.01%, reaching $5.57.
Site Navigation
.jpg)